Try our Advanced Search for more refined results
In re: GERON CORPORATION SECURITIES LITIGATION
Case Number:
3:14-cv-01224
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
March 03, 2017
Geron, Investors Reach $6.25M Settlement In Cancer Drug Suit
A proposed class of Geron Corp. investors have sought approval in California federal court for a $6.25 million settlement regarding claims that the company improperly touted a cancer drug before the U.S. Food and Drug Administration halted a clinical trial over liver toxicity concerns.
-
April 10, 2015
Geron Gets Shareholder Action Over Cancer Drug Trimmed
A California federal judge on Friday trimmed a consolidated proposed shareholder class action accusing Geron Corp. of improperly touting the prospects of its cancer drug imetelstat before the U.S. Food and Drug Administration put a hold on the drug's clinical trial over concerns of liver toxicity.
-
March 19, 2014
Geron Faces Investor Suit After FDA Halts Clinical Trial
Geron Corp. was hit with a shareholder class action Friday in California federal court accusing the drugmaker of improperly touting the prospects of its sole drug candidate before the U.S. Food and Drug Administration put a hold on the drug's clinical trial over concerns of liver toxicity.